Logan Cook, in Martinsville, IN - General Practice

Logan Cook, is a General Practice physician based in Martinsville, Indiana. Logan Cook is licensed to practice in Indiana (license number 1261) and her current practice location is 510 Grand Valley Blvd, Martinsville, Indiana. She can be reached at her office (for appointments etc.) via phone at (765) 516-6292.

NPI number for Logan Cook is 1285335570 and her current mailing address is 510 Grand Valley Blvd, Martinsville, Indiana. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1285335570.

Contact Information

	Logan Cook,
	510 Grand Valley Blvd, Martinsville, IN 46151-5883
	(765) 516-6292
	(765) 349-7688

Physician's Profile

Full Name	Logan Cook
Gender	Female
Speciality	General Practice
Location	510 Grand Valley Blvd, Martinsville, Indiana
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1285335570
Provider Enumeration Date: 03/14/2023
Last Update Date: 03/14/2023

Medical Identifiers

Medical identifiers for Logan Cook such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1285335570	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	1261 (Indiana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Logan Cook is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Logan Cook, 510 Grand Valley Blvd, Martinsville, IN 46151-5883 Ph: (765) 516-6292	Logan Cook, 510 Grand Valley Blvd, Martinsville, IN 46151-5883 Ph: (765) 516-6292

News Archive

EnteroMedics announces pricing of previously announced public offering of common stock

EnteroMedics Inc., a developer and manufacturer of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders, announced the pricing of its previously announced public offering of 40,229,886 units.

Scottish suicide rates in men fall by over 40 percent

In the 1980s and 90s, Scotland was known for its alarmingly high suicide rate. But since 2000, suicide rates have fallen sharply. A study published in the online open access journal BMC Public Health found this reduction is associated with a significant drop in hangings as a means of suicide.

Blogs report on global maternal health conference

Crystal Lander, director of policy and advocacy at Management Sciences for Health (MSH), writes in the MSH "Gobal Health Impact" blog about the Second Global Maternal Health Conference taking place in Arusha, Tanzania, and she describes a speech by Agnes Binagwaho, Rwanda's minister of health. She says of the conference, "So far, the emphasis on multiple voices and knowledge sharing has gotten it off to an excellent start."

Study finds uneven distribution of telemedicine services for mental health in rural areas

Newly published research by Harvard Medical School and the RAND Corporation reveals a dramatic growth in the use of telemedicine for the diagnosis and treatment of mental health disorders in rural areas, but strikingly uneven distribution of services across states.

Bayer announces data from riociguat Phase III trial on CTEPH

Bayer HealthCare today announced data from the Phase III CHEST-1 trial evaluating its investigational drug riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or with persistent or recurrent pulmonary hypertension (PH) after surgery.

Logan Cook, - General Practice in Martinsville, IN